Safety of convalescent sera for the treatment of viral severe acute respiratory syndrome： an experimental model in rhesus macaque  

作　　者：HE Wei-ping LI Bo-an ZHAO Jun CHENG Yun 

机构地区：[1]Liver Disease Center for Military Staff , 302 Hospital of People's Liberation Army, Beijing 100039, China [2]Department of Pharmacy, 302 Hospital of People's Liberation Army, Beijing 100039, China

出　　处：《Chinese Medical Journal》2013年第19期3790-3792,共3页中华医学杂志（英文版）

基　　金：This work was supported by the National Nature Science Foundation of China （No. 30340010） and the Beijing Nature Science Funding （No. 7034050）.

摘　　要：Serotherapy has assumed different clinical roles over the years.With the development of antibiotics,the use of serotherapy to treat bacterial diseases declined.However,interest in viral serotherapy increased due to the lack of a specific therapy for viral infections.Human convalescent sera have been used to treat and prevent measles,mumps,polio,Spanish flu,vaccinia and varicella viral infection,among others.Serotherapy has assumed different clinical roles over the years.With the development of antibiotics,the use of serotherapy to treat bacterial diseases declined.However,interest in viral serotherapy increased due to the lack of a specific therapy for viral infections.Human convalescent sera have been used to treat and prevent measles,mumps,polio,Spanish flu,vaccinia and varicella viral infection,among others.

关 键 词：severe acute respiratory syndrome ＂ convalescent sera SAFETY 

分 类 号：S858.935.3[农业科学—临床兽医学] S858.28[农业科学—兽医学]